US Health Care System is Beginning to Embrace Cost Effectiveness as a Central Component of “Value”

ISPOR publication suggests that the US health care system is beginning to embrace cost effectiveness as a central component of “value”.

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced on 29th August the publication of a series of articles suggesting that the application of cost-effectiveness analysis for health care decision making in the US may be approaching critical mass. This special themed section, “Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?“, was published in the July/August 2016 in Value in Health.

Tagged with

Published 5. September 2016 in News EU